Affymetrix (NASDAQ:AFFX), manufacturer of life sciences instruments, announced that its third quarter could under-perform market expectations as its gene expression and eBioscience divisions could be impacted by a weaker euro and tight funding situations. Q3 revenue is now expected to be about $80 million whereas analysts expected $84.6 million.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Japan’s dispute with China over the ownership of a few islands, and the resultant fall in sales of Japanese cars in China leads three of the former’s biggest car-makers to curtail production in China by almost half. Nissan (NSANY.OB) has suspended the night shift at its two Chinese plants, whereas Toyota (NYSE:TM) and Honda (NYSE:HMC) are cutting shift hours and slowing the rate of production.
UnitedHealth (NYSE:UNH), the largest health benefits and services company in the United States, announces that it will acquire 90 percent of the 359 million outstanding shares of Amil Participações S.A. (BM&FBOVESPA: AMIL3), Brazil’s largest health care company providing health and dental benefits, hospital and clinical services, and advanced care management resources to over 5 million people, for about $4.9 billion in cash. The combination….”is the most compelling growth and value creation opportunity we have seen in years,” says Stephen J. Hemsley, president and CEO of UnitedHealth Group.
Don’t Miss: Why is GM Falling Behind in China?